Back to 
BlackRock, Inc.
BlackRock, Inc.
DNTH7 quarters
Position history for BlackRock, Inc.'s holdings in Dianthus Therapeutics, Inc.
BlackRock, Inc. holds 4.1M shares of DNTH (Dianthus Therapeutics, Inc.), worth $402M as of 2026-Q2. The position was increased (+29.9% shares). DNTH represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$402M
Current Shares
4.1M
Total Value Change
+$366M
Total Shares Change
+2.5M
Quarter-by-Quarter History
Other major holders of DNTH: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP